A bibliometric analysis of vaccination against atherosclerosis

References

• Kong P, Cui Z-Y, Huang X-F, Zhang D-D, Guo R-J, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Sig Transduct Target Ther. 2022;7(1). doi:10.1038/s41392-022-00955-7.
   Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–14. doi:10.1016/j.jacc.2020.11.010.
   PubMed Web of Science ®Google Scholar
• Song L, Zhang J, Ma D, Fan Y, Lai R, Tian W, Zhang Z, Ju J, Xu H. A bibliometric and knowledge-map analysis of macrophage polarization in atherosclerosis from 2001 to 2021. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.910444.
   Google Scholar
• Zhang T, Pang C, Xu M, Zhao Q, Hu Z, Jiang X, Guo M. The role of immune system in atherosclerosis: molecular mechanisms, controversies, and future possibilities. Human Immunol. 2024;85(2):110765. doi:10.1016/j.humimm.2024.110765.
   Web of Science ®Google Scholar
• Ley K. Inflammation and Atherosclerosis. Cells. 2021;10(5):1197. doi:10.3390/cells10051197.
   PubMed Web of Science ®Google Scholar
• Zheng WC, Chan W, Dart A, Shaw JA. Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease. Eur Heart J - Cardiovascular Pharmacotherapy. 2024;10(1):53–67. doi:10.1093/ehjcvp/pvad074.
   Web of Science ®Google Scholar
• Barale C, Melchionda E, Morotti A, Russo I. PCSK9 biology and its role in atherothrombosis. IJMS. 2021;22(11):5880. doi:10.3390/ijms22115880.
   Google Scholar
• Moreno-Gonzalez MA, Ortega-Rivera OA, Steinmetz NF. Two decades of vaccine development against atherosclerosis. Nano Today. 2023;50:101822. doi:10.1016/j.nantod.2023.101822.
   Web of Science ®Google Scholar
• Yin H, Zhang F, Yang X, Meng X, Miao Y, Noor Hussain MS, Yang L, Li Z. Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis. Front Oncol. 2022;12. doi:10.3389/fonc.2022.973999.
   Web of Science ®Google Scholar
• Pranckutė R. Web of Science (WoS) and Scopus: the titans of bibliographic information in today’s academic world. Publications. 2021;9(1):12. doi:10.3390/publications9010012.
   Web of Science ®Google Scholar
• Arruda H, Silva ER, Lessa M, Proença Jr D, Bartholo R. VOSviewer and bibliometrix. J Med Libr Assoc. 2022;110(3):392–5. doi:10.5195/jmla.2022.1434.
   PubMedGoogle Scholar
• Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci USA. 2005;102(46):16569–72. doi:10.1073/pnas.0507655102.
   PubMed Web of Science ®Google Scholar
• Wang S, Tian C, Gao Z, Zhang B, Zhao L. Research status and trends of the diabetic cardiomyopathy in the past 10 years (2012–2021): a bibliometric analysis. Front Cardiovasc Med. 2022;9. doi:10.3389/fcvm.2022.1018841.
   Web of Science ®Google Scholar
• Wei N, Xu Y, Li Y, Shi J, Zhang X, You Y, Sun Q, Zhai H, Hu Y. A bibliometric analysis of T cell and atherosclerosis. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.948314.
   Google Scholar
• Chen Z, Liu Z, Feng Y, Shi A, Wu L, Sang Y, Li C. Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis. Front Immunol. 2024;15. doi:10.3389/fimmu.2024.1259788.
   Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–27. doi:10.1161/CIRCRESAHA.118.313591.
   PubMed Web of Science ®Google Scholar
• Crotty S. T follicular helper cell biology: a decade of discovery and diseases. Immunity. 2019;50(5):1132–48. doi:10.1016/j.immuni.2019.04.011.
   PubMed Web of Science ®Google Scholar
• Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013;13(12):875–87. doi:10.1038/nri3547.
   PubMed Web of Science ®Google Scholar
• Binder CJ, Hörkkö S, Dewan A, Chang M-K, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003;9(6):736–43. doi:10.1038/nm876.
   PubMed Web of Science ®Google Scholar
• Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37(7):1923–32. doi:10.1161/01.STR.0000226901.34927.10.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112(14):2193–200. doi:10.1161/CIRCULATIONAHA.105.535435.
   PubMed Web of Science ®Google Scholar
• Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711–20. doi:10.1001/jama.2013.279206.
   PubMed Web of Science ®Google Scholar
• Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week. J Am Coll Cardiol. 2018;72(17):2071–81. doi:10.1016/j.jacc.2018.08.1043.
   PubMed Web of Science ®Google Scholar
• Rittershaus CW, Miller DP, Thomas LJ, Picard MD, Honan CM, Emmett CD, Pettey CL, Adari H, Hammond RA, Beattie DT, et al. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20(9):2106–12. doi:10.1161/01.ATV.20.9.2106.
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. 2014;30(1):16–22. doi:10.3109/09513590.2013.852531.
   PubMed Web of Science ®Google Scholar
• Zhu X, Hu J, Deng S, Tan Y, Qiu C, Zhang M, Ni X, Lu H, Wang Z, Li L, et al. Comprehensive bibliometric analysis of the kynurenine pathway in mood disorders: focus on gut microbiota research. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.687757.
   Web of Science ®Google Scholar
• Kobiyama K, Saigusa R, Ley K. Vaccination against atherosclerosis. Curr Opin Immunol. 2019;59:15–24. doi:10.1016/j.coi.2019.02.008.
   PubMed Web of Science ®Google Scholar
• Gisterå A, Hermansson A, Strodthoff D, Klement ML, Hedin U, Fredrikson GN, Nilsson J, Hansson GK, Ketelhuth DFJ. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis. J Intern Med. 2017;281(4):383–97. doi:10.1111/joim.12589.
   Web of Science ®Google Scholar
• Su J, Zhou H, Liu X, Nilsson J, Fredrikson GN, Zhao M. oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+/K+ channel flow. J Cellular Molecular Medi. 2017;21(5):929–40. doi:10.1111/jcmm.13033.
   Web of Science ®Google Scholar
• Fröbert O, Götberg M, Angerås O, Jonasson L, Erlinge D, Engstrøm T, Persson J, Jensen SE, Omerovic E, James SK, et al. Design and rationale for the influenza vaccination after myocardial infarction (IAMI) trial. A registry-based randomized clinical trial. Am Heart J. 2017;189:94–102. doi:10.1016/j.ahj.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Fan L, Liu J, Hu W, Chen Z, Lan J, Zhang T, Zhang Y, Wu X, Zhong Z, Zhang D, et al. Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Res. 2024;34(6):407–27. doi:10.1038/s41422-024-00945-0.
   Google Scholar
• Sun H, Krauss RM, Chang JT, Teng BB. PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction. J Lipid Res. 2018;59(2):207–23. doi:10.1194/jlr.M078360.
   Web of Science ®Google Scholar
• Yang J, Ma X, Niu D, Sun Y, Chai X, Deng Y, Wang J, Dong J. PCSK9 inhibitors suppress oxidative stress and inflammation in atherosclerotic development by promoting macrophage autophagy. Am J Transl Res. 2023;15(8):5129–44.
   Web of Science ®Google Scholar
• Ji E, Lee S. Antibody-based therapeutics for atherosclerosis and cardiovascular diseases. Int J Mol Sci. 2021;22(11):5770. doi:10.3390/ijms22115770.
   PubMed Web of Science ®Google Scholar
• Pickett JR, Wu Y, Zacchi LF, Ta HT. Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics. Cardiovascular Research. 2023;119(13):2278–93. doi:10.1093/cvr/cvad130.
   Web of Science ®Google Scholar
• Hutchinson MA, Park HS, Zanotti KJ, Alvarez-Gonzalez J, Zhang J, Zhang L, Telljohann R, Wang M, Lakatta EG, Gearhart PJ, et al. Auto-antibody production during experimental atherosclerosis in ApoE(-/-) mice. Front Immunol. 2021;12:695220. doi:10.3389/fimmu.2021.695220.
   Web of Science ®Google Scholar
• Kyaw T, Cui P, Tay C, Kanellakis P, Hosseini H, Liu E, Rolink AG, Tipping P, Bobik A, Toh B-H, et al. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE−/− mice. PLOS ONE. 2013;8(4):e60430. doi:10.1371/journal.pone.0060430.
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Delgado P, Busse CE, Sanz-Bravo A, Martos-Folgado I, Bonzon-Kulichenko E, Ferrarini A, Gonzalez-Valdes IB, Mur SM, Roldán-Montero R, et al. ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies. Nature. 2021;589(7841):287–92. doi:10.1038/s41586-020-2993-2.
   Web of Science ®Google Scholar
• Hobbs HH, Cohen JC, Horton JD. PCSK9: from nature’s loss to patient’s gain. Circulation. 2024;149(3):171–3. doi:10.1161/CIRCULATIONAHA.123.064498.
   Web of Science ®Google Scholar
• Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA. 1995;92(3):821–5. doi:10.1073/pnas.92.3.821.
   PubMed Web of Science ®Google Scholar
• Ameli S, Hultgårdh-Nilsson A, Regnström J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. ATVB. 1996;16(8):1074–9. doi:10.1161/01.ATV.16.8.1074.
   Google Scholar
• George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, Kopolovic Y, Wick G, Shoenfeld Y, Harats D, et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998;138(1):147–52. doi:10.1016/S0021-9150(98)00015-X.
   PubMed Web of Science ®Google Scholar
• Freigang S, Hörkkö S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor–deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. ATVB. 1998;18(12):1972–82. doi:10.1161/01.ATV.18.12.1972.
   Google Scholar
• Baardman J, Lutgens E. Regulatory T Cell Metabolism in Atherosclerosis. Metabolites. 2020;10(7):279. doi:10.3390/metabo10070279.
   PubMed Web of Science ®Google Scholar
• Kimura T, Kobiyama K, Winkels H, Tse K, Miller J, Vassallo M, Wolf D, Ryden C, Orecchioni M, Dileepan T, et al. Regulatory CD4+ T cells recognize major histocompatibility complex class II molecule–restricted peptide epitopes of apolipoprotein B. Circulation. 2018;138(11):1130–43. doi:10.1161/CIRCULATIONAHA.117.031420.
   PubMed Web of Science ®Google Scholar
• Chyu KY, Dimayuga PC, Shah PK. Vaccine against arteriosclerosis: an update. Ther Adv Vaccines. 2017;5(2):39–47. doi:10.1177/2051013617693753.
   PubMedGoogle Scholar
• Kimura T, Tse K, Sette A, Ley K. Vaccination to modulate atherosclerosis. Autoimmunity. 2015;48(3):152–60. doi:10.3109/08916934.2014.1003641.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao X, Yu K, Shi H, Zhu R, Mao X. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis. Clinical And Experimental Immunology. 2016;183(3):452–68. doi:10.1111/cei.12726.
   Web of Science ®Google Scholar
• Wick C, Onestingel E, Demetz E, Dietrich H, Wick G. Oral Tolerization with mycobacterial heat shock protein 65 reduces chronic experimental atherosclerosis in aged mice. Gerontology. 2018;64(1):36–48. doi:10.1159/000480436.
   Web of Science ®Google Scholar
• de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res. 2004;45(11):1967–74. doi:10.1194/jlr.R400007-JLR200.
   PubMed Web of Science ®Google Scholar
• Riascos-Bernal DF, Ressa G, Korrapati A, Sibinga NES. The FAT1 cadherin drives vascular smooth muscle cell migration. Cells. 2023;12(12):1621. doi:10.3390/cells12121621.
   Web of Science ®Google Scholar
• Ma Z, Mao C, Chen X, Yang S, Qiu Z, Yu B, Jia Y, Wu C, Wang Y, Wang Y, et al. Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia. Circulation. 2023;147(9):728–42. doi:10.1161/CIRCULATIONAHA.122.061516.
   PubMed Web of Science ®Google Scholar
• Ha HS, Kim TY, Han SJ, Sung H-J, Seo KY, Ha J-W. Anti-atherosclerotic vaccination against Porphyromonas gingivalis as a potential comparator of statin in mice. PeerJ. 2021;9:e11293. doi:10.7717/peerj.11293.
   PubMed Web of Science ®Google Scholar
• Gurven MD, Finch CE, Wann LS. Are intestinal worms nature’s anti-atherosclerosis vaccine? Eur Heart J. 2018;39(18):1653. doi:10.1093/eurheartj/ehy129.
   Web of Science ®Google Scholar
• Moseley P, Klenerman P, Kadambari S. Indirect effects of cytomegalovirus infection: implications for vaccine development. Rev Med Virol. 2023;33(1):e2405. doi:10.1002/rmv.2405.
   Web of Science ®Google Scholar
• Saleki K, Alijanizade P, Moradi S, Rahmani A, Banazadeh M, Mohamadi MH, Shahabi F, Nouri HR. Engineering a novel immunogenic chimera protein utilizing bacterial infections associated with atherosclerosis to induce a deviation in adaptive immune responses via immunoinformatics approaches. Infect Genet Evol. 2022;102:105290. doi:10.1016/j.meegid.2022.105290.
   PubMed Web of Science ®Google Scholar
• Jun L, Jie L, Dongping Y, Xin Y, Taiming L, Rongyue C, Jie W, Jingjing L. Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis. Vaccine. 2012;30(6):1029–37. doi:10.1016/j.vaccine.2011.12.043.
   PubMed Web of Science ®Google Scholar
• Lu X, Xia M, Endresz V, Faludi I, Szabo A, Gonczol E, Mundkur L, Chen D, Kakkar V. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice. Atherosclerosis. 2012;225(1):56–68. doi:10.1016/j.atherosclerosis.2012.07.021.
   Web of Science ®Google Scholar
• Roy P, Ali AJ, Kobiyama K, Ghosheh Y, Ley K. Opportunities for an atherosclerosis vaccine: from mice to humans. Vaccine. 2020;38(28):4495–506. doi:10.1016/j.vaccine.2019.12.039.
   Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553–70. doi:10.1161/CIRCRESAHA.120.316242.
   PubMed Web of Science ®Google Scholar
• Zou Y, Song X, Liu N, Sun W, Liu B. Intestinal flora: a potential new regulator of cardiovascular disease. Aging Dis. 2022;13(3):753–72. doi:10.14336/AD.2021.1022.
   Web of Science ®Google Scholar
• Hinkley H, Counts DA, VonCanon E, Lacy M. T cells in atherosclerosis: key players in the pathogenesis of vascular disease. Cells. 2023;12(17):2152. doi:10.3390/cells12172152.
   Web of Science ®Google Scholar
• Taylor JA, Hutchinson MA, Gearhart PJ, Maul RW. Antibodies in action: the role of humoral immunity in the fight against atherosclerosis. Immun Ageing. 2022;19(1):59. doi:10.1186/s12979-022-00316-6.
   Web of Science ®Google Scholar
• Wigren M, Kolbus D, Dunér P, Ljungcrantz I, Söderberg I, Björkbacka H, Fredrikson GN, Nilsson J. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med. 2011;269(5):546–56. doi:10.1111/j.1365-2796.2010.02311.x.
   PubMed Web of Science ®Google Scholar
• Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19(12):1597–608. doi:10.1038/nm.3409.
   PubMed Web of Science ®Google Scholar
• Kobiyama K, Vassallo M, Mitzi J, Winkels H, Pei H, Kimura T, Miller J, Wolf D, Ley K. A clinically applicable adjuvant for an atherosclerosis vaccine in mice. Eur J Immunol. 2018;48(9):1580–7. doi:10.1002/eji.201847584.
   Web of Science ®Google Scholar
• Jing J, Zhu C, Gong R, Qi X, Zhang Y, Zhang Z. Research progress on the active ingredients of traditional Chinese medicine in the intervention of atherosclerosis: a promising natural immunotherapeutic adjuvant. Biomed Pharmacother= Biomedecine & Pharmacotherapie. 2023;159:114201. doi:10.1016/j.biopha.2022.114201.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Shajari N, Davudian S, Salehi S, Baradaran B. Nano-liposome-based target toxicity machine: an alternative/complementary approach in atopic diseases. Artif Cells, Nanomed Biotechnol. 2017;45(7):1292–7. doi:10.1080/21691401.2016.1261872.
   PubMed Web of Science ®Google Scholar
• Kashiwagi S. Laser adjuvant for vaccination. Faseb J. 2020;34(3):3485–500. doi:10.1096/fj.201902164R.
   PubMed Web of Science ®Google Scholar
• Nettersheim FS, De Vore L, Winkels H. Vaccination in atherosclerosis. Cells. 2020;9(12):2560. doi:10.3390/cells9122560.
   PubMed Web of Science ®Google Scholar
• Chyu KY, Reyes OS, Zhao X, Yano J, Dimayuga P, Nilsson J, Cercek B, Shah PK. Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (−/−) mice. Atherosclerosis. 2004;176(1):27–35. doi:10.1016/j.atherosclerosis.2004.04.016.
   Web of Science ®Google Scholar
• Hu Y, Chen Z, Jiang L, Chen F, Jin R, Cheng L. Effects of oral and subcutaneous administration of HSP60 on myeloid-derived suppressor cells and atherosclerosis in ApoE−/− mice. Biochem Bioph Res Co. 2018;498(4):701–6. doi:10.1016/j.bbrc.2017.10.150.
   Web of Science ®Google Scholar
• Calixto-Tlacomulco S, Luna-Reyes I, Delgado-Coello B, Gutiérrez-Vidal R, Reyes-Grajeda JP, Mas-Oliva J. CETP-derived peptide seq-1, the key component of HB-ATV-8 vaccine prevents stress responses, and promotes downregulation of pro-fibrotic genes in hepatocytes and stellate cells. Arch Med Res. 2024;55(2):102937. doi:10.1016/j.arcmed.2023.102937.
   Web of Science ®Google Scholar